MENU
NUVL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nuvalent (NUVL) Ownership - Who owns Nuvalent?
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer... Show more
Profile
Industry
N/A
Address
One Broadway
Phone
+1 857 357-7000
Employees
92
Web
https://www.nuvalent.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.3B
P/E Ratio
N/A
Total Cash
1.12B
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.00
Dividend Yield
N/A
Total Cash/Share
15.62
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NUVL
Capitalization
5.3B
P/E Ratio
N/A
Risk (Beta)
1.00
Dividend Yield
N/A
Total Cash
1.12B
Total Cash/Share
15.62
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.07B
P/B Ratio
4.95
Cash Flow
N/A
Earnings
-3.93
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
8K
Current Ratio
20.96
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-280.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.83
Shares Held By Institutions
7.65B
Shares Outstanding - Current
71.6M
Total Liabilities
72M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-5.493
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Broadway
Phone
+1 857 357-7000
Employees
92
Web
https://www.nuvalent.com